124 related articles for article (PubMed ID: 4764146)
1. An evaluation of a new antiviral agent "virazole" against influenza virus infections.
Suganuma T; Ishida N
Tohoku J Exp Med; 1973 Aug; 110(4):405-6. PubMed ID: 4764146
[No Abstract] [Full Text] [Related]
2. In vitro effect of virazole against influenza viruses.
Togo Y
Antimicrob Agents Chemother; 1973 Dec; 4(6):641-2. PubMed ID: 4793883
[TBL] [Abstract][Full Text] [Related]
3. Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice.
Khare GP; Sidwell RW; Witkowski JT; Simon LN; Robins RK
Antimicrob Agents Chemother; 1973 Apr; 3(4):517-22. PubMed ID: 4790606
[TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.
Sidwell RW; Huffman JH; Khare GP; Allen LB; Witkowski JT; Robins RK
Science; 1972 Aug; 177(4050):705-6. PubMed ID: 4340949
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides.
Witkowski JT; Robins RK; Khare GP; Sidwell RW
J Med Chem; 1973 Aug; 16(8):935-7. PubMed ID: 4355593
[No Abstract] [Full Text] [Related]
6. In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses.
Huffman JH; Sidwell RW; Khare GP; Witkowski JT; Allen LB; Robins RK
Antimicrob Agents Chemother; 1973 Feb; 3(2):235-41. PubMed ID: 4208281
[TBL] [Abstract][Full Text] [Related]
7. [Favipiravir, a new concept of antiviral drug against influenza viruses].
Reina J; Reina N
Rev Esp Quimioter; 2017 Apr; 30(2):79-83. PubMed ID: 28176519
[TBL] [Abstract][Full Text] [Related]
8. The in vitro and in vivo effect of chemotherapeutic agents on the Marek's disease herpesvirus of chickens.
Eidson CS; Than VT; Kleven SH
Poult Sci; 1974 Jul; 53(4):1533-8. PubMed ID: 4854877
[No Abstract] [Full Text] [Related]
9. Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals.
Sidwell RW; Allen LB; Khare GP; Huffman JH; Witkowski JT; Simon LN; Robins RK
Antimicrob Agents Chemother; 1973 Feb; 3(2):242-6. PubMed ID: 4790589
[TBL] [Abstract][Full Text] [Related]
10. Combined action of ribovirin and rimantadine in experimental myxovirus infection.
Galegov GA; Pushkarskaya NL; Obrosova-Serova NP; Zhdanov VM
Experientia; 1977 Jul; 33(7):905-6. PubMed ID: 891769
[No Abstract] [Full Text] [Related]
11. New Flu Antiviral Candidate May Thwart Drug Resistance.
Hampton T
JAMA; 2020 Jan; 323(1):17. PubMed ID: 31910262
[No Abstract] [Full Text] [Related]
12. Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides.
Witkowski JT; Robins RK; Sidwell RW; Simon LN
J Med Chem; 1972 Nov; 15(11):1150-4. PubMed ID: 4347550
[No Abstract] [Full Text] [Related]
13. [Comparative evaluation of the therapeutic effectiveness of virazole and remantadine in patients with influenza caused by A(H3N2) and B viruses].
Kolobukhina LV; Krylov VF; Grushinskaia IA; Ivanova LA; Poliakova TG
Vopr Virusol; 1985; 30(3):296-8. PubMed ID: 4049841
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin (virazole): a novel antiviral agent against viral respiratory tract infections.
Ahmed ME; Branch RA
Ration Drug Ther; 1986 Nov; 20(11):1-3. PubMed ID: 3588934
[No Abstract] [Full Text] [Related]
15. Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19.
Ison MG; Scheetz MH
EBioMedicine; 2021 Jan; 63():103204. PubMed ID: 33418497
[No Abstract] [Full Text] [Related]
16. [Clinical study of the antiviral preparation ML-76 in influenza].
Iakushin AI; Trantseeva TB
Tr Inst Im Pastera; 1985; 63():42-7. PubMed ID: 3916352
[No Abstract] [Full Text] [Related]
17. [Action of 1-beta-D-ribofuranosyl, 1,2,4-triazol-3-carboxamide on the treatment of acute viral hepatitis].
Zuñiga CB; de Almeida C; Iervolino AC; Castro Ide O; Galvão PA
AMB Rev Assoc Med Bras; 1974 Nov; 20(11):386-90. PubMed ID: 4615344
[No Abstract] [Full Text] [Related]
18. [Effect of virazole on the antiviral activity of poly(G) X poly(C) and other polyribonucleotide interferonogens].
Vil'ner LM; Lashkevich VA
Antibiotiki; 1984 Jun; 29(6):450-3. PubMed ID: 6089650
[TBL] [Abstract][Full Text] [Related]
19. [Antiinfluenza virus activity of virazole by means of quantitative hemadsorption technique (author's transl)].
Shinkai K; Nishimura T
Uirusu; 1974 Aug; 24(2):175-80. PubMed ID: 4478988
[No Abstract] [Full Text] [Related]
20. [Ribavirin as an antiviral agent: chemistry, molecular mechanism of action and possibilities of use (review)].
Galegov GA; L'vov ND; Petrova IG; Florent'ev VL
Vopr Med Khim; 1986; 32(1):10-9. PubMed ID: 3513441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
